All premises where intravenous infusion therapy (IVIT) procedures are performed are required to track Type 2 occurrences and report them to the College by May 1 each year. This requirement also applies to premises that have not had any Type 2 occurrences.
Type 2 occurrences are defined in the General Regulation as:
• any infection occurring in a patient in the premises after an IVIT procedure was performed at the premises,
• an unscheduled treatment of a patient by a Member occurring within five days after an IVIT procedure was performed at the premises, or
• any adverse drug reaction occurring in a patient after an IVIT procedure was performed at the premises.
The first Type 2 occurrences reporting period (March 2, 2017 to March 1, 2018) saw a 100% response rate from designated members. We would like to acknowledge and thank all our IVIT Members who made the effort to meet the requirements of the Inspection Program and work with the inspectors during their premises inspections. The first reporting period also noted that 15% of authorized premises reported one or more occurrence. Download the table below for a complete list of reported type 2 occurrences.